Cargando…
Core Outcome Measures in Preclinical Assessment of Candidate Analgesics
All preclinical procedures for analgesic drug discovery involve two components: 1) a “pain stimulus” (the principal independent variable), which is delivered to an experimental subject with the intention of producing a pain state; and 2) a “pain behavior” (the principal dependent variable), which is...
Autor principal: | Negus, S. Stevens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448246/ https://www.ncbi.nlm.nih.gov/pubmed/30898855 http://dx.doi.org/10.1124/pr.118.017210 |
Ejemplares similares
-
Editorial: Preclinical Animal Models and Measures of Pain: Improving Predictive Validity for Analgesic Drug Development
por: Tappe-Theodor, Anke, et al.
Publicado: (2022) -
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration
por: Banks, Matthew L., et al.
Publicado: (2012) -
Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure
por: Banks, Matthew L., et al.
Publicado: (2015) -
Climbing behavior by mice as an endpoint for preclinical assessment of drug effects in the absence and presence of pain
por: Santos, Edna J., et al.
Publicado: (2023) -
An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy
por: Koyama, Suguru, et al.
Publicado: (2018)